Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion type Assertion NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_head.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion evidence source_evidence_literature NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion SIO_000772 23033490 NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion wasDerivedFrom befree-20140225 NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion wasGeneratedBy ECO_0000203 NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.